retatrutide and mots c vs Retatrutide + MOTS-c Peptide Stack
Description
A 12-week trial at 1.0mg showed semaglutide reduced energy intake by approximately 35% versus placebo
Report within 24 hours of delivery
The firm noted that the FDA did not distinguish between oral and injectable GLP-1 products in its warning, raising the risk that regulatory scrutiny could extend to Hims injectable semaglutide offerings
It took us over 18mths to perfect the formula & taste profile
In this study, there was about a 7% placebo-adjusted reduction in bodyweight with the combination and about 2% and 4% with canagliflozin or phentermine alone, respectively [42]
Constipation: Another common side effect is constipation, likely due to slower gastric emptying
